GLASGOW NEURO LTD

Company Registration Number:
SC533018 (Scotland)

Unaudited micro entity accounts for the year ended 30 April 2025

Period of accounts

Start date: 01 May 2024

End date: 30 April 2025

GLASGOW NEURO LTD

Contents of the Financial Statements

for the Period Ended 30 April 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

GLASGOW NEURO LTD

Company Information

for the Period Ended 30 April 2025




Director: Bernd Porr
Registered office: 48 West George Street
West George Street
Office 2/3
Glasgow
GB-SCT
G2 1BP
Company Registration Number: SC533018 (Scotland)

GLASGOW NEURO LTD

Directors' Report Period Ended 30 April 2025

The directors present their report with the financial statements of the company for the period ended 30 April 2025

Principal Activities

The company has been selling the biomedical amplifier Attys and did consultancy for the automotive industry.

Directors

The directors shown below have held office during the whole of the period from 01 May 2024 to 30 April 2025
Bernd Porr

This report was approved by the board of directors on 17 June 2025
And Signed On Behalf Of The Board By:

Name: Bernd Porr
Status: Director

GLASGOW NEURO LTD

Profit and Loss Account

for the Period Ended 30 April 2025


2025
£

2024
£
Turnover 8,810 9,953
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 3,309 ) ( 8,438 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 113 ) ( 144 )
Other charges ( 1,712 ) ( 3,095 )
Tax on Profit ( 720 ) ( 0 )
Profit or (Loss) for Period 2,956 ( 1,724 )

GLASGOW NEURO LTD

Balance sheet

As at 30 April 2025


2025
£

2024
£
Called up share capital not paid: 0 0
Fixed Assets: 113 226
Current assets: 9,968 17,593
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 9,968 17,593
Total assets less current liabilities: 10,081 17,819
Total net assets (liabilities): 10,081 17,819
Capital and reserves: 10,081 17,819

GLASGOW NEURO LTD

Balance sheet continued

For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 17 June 2025
And Signed On Behalf Of The Board By:

Name: Bernd Porr
Status: Director

The notes form part of these financial statements

GLASGOW NEURO LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2025

  • 1. Employee Information

    Average number of employees: 0

GLASGOW NEURO LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2025

  • 2. Off balance sheet disclosure

    No